Burlington, MA, United States of America

Akash Jain

This inventor holds 1 USPTO granted patent. Top assignee: Cubist Pharmaceuticals, Incorporated. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akash Jain. Retrieved from https://idiyas.com/inventor/akash-jain-5o9nr9ls

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akash Jain: Innovator in Pharmaceutical Chemistry

Introduction

Akash Jain is a notable inventor based in Burlington, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds.

Latest Patents

One of his key patents is titled "Crystalline form of a β-lactamase inhibitor." This disclosure provides compositions containing solid forms of sodium (2S,5R)-2-(1,3,4-oxadiazol-2-yl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate, along with methods of manufacturing and using these compositions. This innovation is crucial for enhancing the efficacy of antibiotic treatments.

Career Highlights

Akash Jain is currently employed at Cubist Pharmaceuticals, Incorporated, where he continues to advance his research and development efforts. His work focuses on creating effective solutions to combat bacterial resistance.

Collaborations

He has collaborated with esteemed colleagues, including You Seok Hwang and Jian-Qiao Gu, to further enhance the impact of his research in the pharmaceutical industry.

Conclusion

Akash Jain's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his role as a key inventor in the field. His ongoing work at Cubist Pharmaceuticals continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…